Sunway's Outlook Supported by Healthcare Sector Growth -- Market Talk

Dow Jones

2024/11/28

0210 GMT - Sunway's outlook is supported by its strategic presence in the fast-growing healthcare sector and its position as a key beneficiary of the Johor-Singapore Special Economic Zone, TA Securities analyst Thiam Chiann Wen says in a note. Despite a 20% share-price gain in the past three months, she anticipates further upside leading up to Sunway Healthcare Group's impending IPO, which is likely to occur by early 2026, ahead of the 2027 deadline agreed with 16% shareholder GIC. The healthcare unit's IPO could also result in share distributions or special dividends, as seen with the prior spinoff of its construction unit, she reckons. TA Securities raises Sunway's target price to MYR5.60 from MYR4.76, while maintaining a buy rating on the stock. Shares are 1.6% lower at MYR4.82. (yingxian.wong@wsj.com)

(END) Dow Jones Newswires

November 27, 2024 21:10 ET (02:10 GMT)

应版权方要求，你需要登录查看该内容

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2486339267"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2486339267\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2486339267?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-28 10:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2486339267","market":"us","top_or_hot":-1,"title":"Sunway's Outlook Supported by Healthcare Sector Growth -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0210 GMT - Sunway's outlook is supported by its strategic presence in the fast-growing healthcare sector and its position as a key beneficiary of the Johor-Singapore Special Economic Zone, TA Securities analyst Thiam Chiann Wen says in a note. Despite a 20% share-price gain in the past three months, she anticipates further upside leading up to Sunway Healthcare Group's impending IPO, which is likely to occur by early 2026, ahead of the 2027 deadline agreed with 16% shareholder GIC. The healthcare unit's IPO could also result in share distributions or special dividends, as seen with the prior spinoff of its construction unit, she reckons. TA Securities raises Sunway's target price to MYR5.60 from MYR4.76, while maintaining a buy rating on the stock. Shares are 1.6% lower at MYR4.82. (yingxian.wong@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 27, 2024 21:10 ET (02:10 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sunway's Outlook Supported by Healthcare Sector Growth -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSunway's Outlook Supported by Healthcare Sector Growth -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2024-11-28 10:10</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0210 GMT - Sunway's outlook is supported by its strategic presence in the fast-growing healthcare sector and its position as a key beneficiary of the Johor-Singapore Special Economic Zone, TA Securities analyst Thiam Chiann Wen says in a note. Despite a 20% share-price gain in the past three months, she anticipates further upside leading up to Sunway Healthcare Group's impending IPO, which is likely to occur by early 2026, ahead of the 2027 deadline agreed with 16% shareholder GIC. The healthcare unit's IPO could also result in share distributions or special dividends, as seen with the prior spinoff of its construction unit, she reckons. TA Securities raises Sunway's target price to MYR5.60 from MYR4.76, while maintaining a buy rating on the stock. Shares are 1.6% lower at MYR4.82. (yingxian.wong@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 27, 2024 21:10 ET (02:10 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HCSG","symbol_name":"Healthcare Svcs Group Inc","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2486339267","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2486339267","pubTimestamp":1732759800,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"0210 GMT - Sunway's outlook is supported by its strategic presence in the fast-growing healthcare sector and its position as a key beneficiary of the Johor-Singapore Special Economic Zone, TA Securities analyst Thiam Chiann Wen says in a note. Despite a 20% share-price gain in the past three months, she anticipates further upside leading up to Sunway Healthcare Group's impending IPO, which is likely to occur by early 2026, ahead of the 2027 deadline agreed with 16% shareholder GIC. The healthcare unit's IPO could also result in share distributions or special dividends, as seen with the prior spinoff of its construction unit, she reckons. TA Securities raises Sunway's target price to MYR5.60 from MYR4.76, while maintaining a buy rating on the stock. Shares are 1.6% lower at MYR4.82. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HCSG":"Healthcare Svcs Group Inc","BK6512":"房地产股","BK4137":"综合支持服务","BK6045":"建筑与工程","PA3.SI":"长益"},"translate_title":"双威的前景受到医疗保健行业增长的支持——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PA3.SI":0.7,"HCSG":1},"content_text":"0210 GMT - Sunway's outlook is supported by its strategic presence in the fast-growing healthcare sector and its position as a key beneficiary of the Johor-Singapore Special Economic Zone, TA Securities analyst Thiam Chiann Wen says in a note. Despite a 20% share-price gain in the past three months, she anticipates further upside leading up to Sunway Healthcare Group's impending IPO, which is likely to occur by early 2026, ahead of the 2027 deadline agreed with 16% shareholder GIC. The healthcare unit's IPO could also result in share distributions or special dividends, as seen with the prior spinoff of its construction unit, she reckons. TA Securities raises Sunway's target price to MYR5.60 from MYR4.76, while maintaining a buy rating on the stock. Shares are 1.6% lower at MYR4.82. (yingxian.wong@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 27, 2024 21:10 ET (02:10 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}